Page 7 - Uli Hacksell News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Bulletin from the annual general meeting in SynAct Pharma AB on 21 May 2021 Today, on 21 May 2021, the annual general meeting was held in SynAct Pharma AB. In light of the ongoing Covid-19 pandemic and in order to reduce the risk of infection spreading, the annual general meeting was held only by advance voting (postal vote) in accordance with temporary legislation. A summary of the adopted resolutions follows below. All resolutions were adopted with the required majority of votes. Resolution on adoption of accounts and allocation of the company’s result Uppdaterad...

Annual General Meeting of Active Biotech AB PRESS RELEASE The Annual General Meeting of Active Biotech was held on May 19, 2021. Due to the extraordinary situation as a result of the COVID-19 pandemic, the Meeting was carried out through postal voting, without any physical attendance. The following main resolutions were passed. In accordance with the Board of Directors' proposal, it was resolved that no dividend would be paid for the financial year 2020, the Company's accumulated loss shall be carried forward. The members of the Board and the CEO were discharged from liability with respect to...

Annual General Meeting of Active Biotech AB PRESS RELEASE The Annual General Meeting of Active Biotech was held on May 19, 2021. Due to the extraordinary situation as a result of the COVID-19 pandemic, the Meeting was carried out through postal voting, without any physical attendance. The following main resolutions were passed. In accordance with the Board of Directors’ proposal, it was resolved that no dividend would be paid for the financial year 2020, the Company’s accumulated loss shall be carried forward. The members of the Board and the CEO were discharged from liability with respec...

Resolutions at the Annual General Meeting in Medivir on 5 May 2021 News provided by Share this article HUDDINGE, Sweden, May 5, 2021 /PRNewswire/ -- Approval of profit and loss accounts and balance sheets, and discharge from liability of the board members and the managing director The annual general meeting in Medivir Aktiebolag (publ) on 5 May 2021 resolved to approve the profit and loss accounts and balance sheets for the financial year 2020. The persons who had been board members and managing directors were discharged from liability with respect to their respective management of the compan...

Financing secured to bring the MIV-818 study into the next phase January – March Net turnover amounted to SEK 9.9 (7.3) million. The loss before interest, tax, depreciation and amortization (EBITDA) amounted to SEK -7.2 (-20.7) million. Basic and diluted earnings per share amounted to SEK -0.18 (-0.96) and SEK -0.18 (-0.96) respectively. Cash flow from operating activities amounted to SEK -1.5 (-16.6) million. Liquid assets and short-term investments at the end of the period amounted to SEK 269.3 (116.6) million. Significant events during the quarter In January the company signed an excl...